Get the Stockscreener App
1.235
14.83%
-0.215
Valion Bio Inc stock is traded at $1.235, with a volume of 13.31M.
It is down -14.83% in the last 24 hours and down -41.47% over the past month.
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
See More
Previous Close:
$1.45
Open:
$1.11
24h Volume:
13.31M
Relative Volume:
55.96
Market Cap:
$1.10M
Revenue:
$232.00K
Net Income/Loss:
$-12.13M
P/E Ratio:
-0.1381
EPS:
-8.9454
Net Cash Flow:
$-10.29M
1W Performance:
-44.12%
1M Performance:
-41.47%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.11
$1.33
1-Week Range:
$1.435
$2.2699
52-Week Range:
$1.11
$32.50
Valion Bio Inc Stock (VBIO) Company Profile
Name
Valion Bio Inc
Sector
Industry
Phone
(888)276-6888
Address
1305 E. HOUSTON STREET, SAN ANTONIO
Compare VBIO vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VBIO
Valion Bio Inc
|
1.235 | 1.10M | 232.00K | -12.13M | -10.29M | -8.9454 |
VRTX
Vertex Pharmaceuticals Inc
|
508.71 | 128.94B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
238.63 | 95.27B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.98 | 82.36B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
855.28 | 53.79B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.53 | 42.37B | 5.76B | 514.49M | 1.10B | 4.4813 |
Valion Bio Inc Stock (VBIO) Latest News
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
Form PRE 14A Valion Bio Inc For: 12 October By Investing.com - Investing.com India
A potential radiation drug could be absorbed through the mouth instead of injected. - Stock Titan
Valion Bio Secures Additional Series B Preferred Financing - The Globe and Mail
Up to $5M in stock is included in Valion Bio (NASDAQ: VBIO)'s proposed securities offering. - Stock Titan
About $35.6 million in U.S. funding supports Valion's experimental drug for radiation sickness - Stock Titan
Valion Bio Announces Completion of Entolimod Oral Mucosal Formulation Development - kalkinemedia.com
If developed and authorized or approved, a needle-free radiation drug could have ~10–40x the dose potential of injections. - Stock Titan
Form 4 Valion Bio Inc For: 24 September - Investing.com India
Form 4 Valion Bio Inc For: 24 September By Investing.com - Investing.com Canada
A 50,000-unit award for Valion Bio (VBIO) interim CEO Zikria Dean is set to start vesting December 22. - Stock Titan
After a 1-for-25 reverse stock split, Valion Bio (VBIO) executive reports a stock-unit settlement. - Stock Titan
A former Pfizer strategist is Valion Bio's interim CEO - Stock Titan
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule - The Globe and Mail
Valion Bio's shares met Nasdaq's $1 minimum. The listing matter is closed. - Stock Titan
Valion Bio Insider Report Highlights Jensen Thomas as Director, Ticker VBIO - Kalkine Media
Inmune Bio (NASDAQ: INMB) grants 100,000 stock options to new director - Stock Titan
Valion Bio (VBIO) director reports zero share stake - Stock Titan
Investor group in Valion Bio (VBIO) shifts to passive stake - Stock Titan
Valion Bio Announces Changes to Management and Board of Directors - ACCESS Newswire
3i's $16.3M note in Valion Bio (VBIO) carries a 9.99% cap - Stock Titan
Aberdeen Income Credit Strategies Fund (ACP-PA) Peer Comparison – Compare with Others - Value Research
3i invests $7.7M in Valion Bio (VBIO) via preferreds and warrants - Stock Titan
Valion Bio appoints CFO Lisa Wolf as president, COO - TipRanks
Valion Bio's Ownership Structure Based on 32,140,634 Shares Outstanding (NASDAQ: VBIO) - kalkinemedia.com
Valion Bio Expands Lisa Wolf’s Role, Adds Two Board Directors - citybiz
Valion Bio names Lisa Wolf president and COO, adds directors - Investing.com
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com Nigeria
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com UK
Valion Bio Announces Changes to Management and Board of Directors - The Globe and Mail
Valion Bio raises capital via new preferred financing - TipRanks
Valion Bio appoints Jared Malbin and Thomas Jensen to its board - TradingView
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com India
Valion Bio Raises $7.74 Million Via Series B/C Preferred and Warrants From 3i - TradingView
Valion Bio, Inc. Common Stock (VBIO) Financials 2026Income Statement and Balance Sheet - MarketBeat
Valion Bio Inc (VBIO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
3i group holds sub-10% Valion Bio (VBIO) stake with warrants, note - Stock Titan
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
Valion Bio Inc (VBIO) Peer Comparison – Compare with Others - Value Research
Valion Bio Announces 1-for-25 Reverse Stock Split to Regain Nasdaq Compliance - Minichart
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com India
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com UK
Valion Bio Announces Reverse Stock Split - ACCESS Newswire
News by ACCESS Newswire on TradingView, 2026-08-27 - TradingView
Valion Bio Announces Reverse Stock Split - Yahoo Finance
Valion Bio announces 1-for-25 reverse stock split - Investing.com
Valion Bio (VBIO) holder nears 10% after big preferred swap - stocktitan.net
Valion Bio, Inc. SEC Filing (Aug 24, 2026) - Stock Titan
3i injects cash into Valion Bio (VBIO) under tight ownership cap - Stock Titan
Valion Bio Inc Stock (VBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Valion Bio Inc Stock (VBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Valauri Christina Rizopoulos | Director |
Apr 01 '26 |
Buy |
0.95 |
19,000 |
18,008 |
19,000 |
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):